GlassScriptPhysician profile
Jonathan Edward Silverman
NPI 1992047492
$233,841.19
in general payments reported to CMS, 2019-2025
22 companies · $78K in 2025
The $78K reported for 2025 was more than what 99% of Pain Medicine (Physical Medicine & Rehabilitation) providers received nationally (typical 2025 total: $400).
See the full distribution for Pain Medicine (Physical Medicine & Rehabilitation)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,926 · 2020: $1,461 · 2021: $1,194 · 2022: $19K · 2023: $44K · 2024: $88K · 2025: $78K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $133K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $27K · Travel and Lodging: $26K · Food and Beverage: $13K · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $11K.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $132,606.25 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $27,475.00 |
| Travel and Lodging | $25,612.88 |
| Food and Beverage | $13,367.08 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $10,734.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Curonix LLC | $126,131.71 | 2022-2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Abbott Laboratories | $68,234.13 | 2021-2025 | Proclaim, Viewmate, Prodigy |
| Boston Scientific Corporation | $21,739.12 | 2019-2025 | Wavewriter Alpha Prime 16, Clinical Trial Product, General - Pain Management |
| Stimwave Technologies Incorporated | $9,172.43 | 2019-2022 | |
| Medtronic, INC. | $2,632.66 | 2021-2024 | Kyphon Express II Kyphopak Tray, Intellis Adaptivestim, Mcgrath Mac |
| Spinal Simplicity, LLC | $1,634.06 | 2024-2025 | Ha Minuteman G3-R, Liberty Si |
| Vertiflex, INC. | $1,286.65 | 2019 | |
| Vertos Medical, INC. | $1,128.93 | 2021-2024 | Mild Device Kit |
| Medtronic USA, INC. | $389.52 | 2019-2020 | |
| Biotronik Nro, INC. | $380.15 | 2025 | Prospera |
| Nevro Corp. | $221.86 | 2019-2021 | |
| Saluda Medical Americas, INC. | $217.18 | 2025 | Evoke |
| Portola Pharmaceuticals, LLC | $127.10 | 2019 | |
| Globus Medical, INC. | $123.89 | 2025 | Senza, Vyrsa V1 |
| Medline Industries LP | $102.38 | 2024 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Si-Bone, INC. | $95.93 | 2021 | |
| Spr Therapeutics, INC | $87.04 | 2025 | Sprint Pns System |
| Carbofix Orthopedics INC | $43.05 | 2023 | |
| Ethicon US, LLC | $25.05 | 2023 | Dermabond Prineo, Stratafix |
| Ferring Pharmaceuticals INC. | $24.25 | 2023 | Euflexxa |
| Painteq LLC | $22.66 | 2024 | Painteq |
| Sanofi-Aventis U.S. LLC | $21.44 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Silverman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.